Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20

Share Price Information for Osirium Tech (OSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
OSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update

18 Jul 2023 07:00

RNS Number : 2822G
Osirium Technologies PLC
18 July 2023
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

 

18 July 2023

 

Osirium Technologies plc

("Osirium" or the "Group")

 

Half Year Trading Update

 

Strong ARR growth reflecting customer demand

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity and IT automation software, announces an update on trading for the six months ended 30 June 2023.

Trading

The Board is pleased to report that Osirium's annual recurring revenue ("ARR") has increased by 34% over the 12 months to 30 June 2023 to £2.16 million (30 June 2022 ARR: £1.61 million) and by 20% since the start of the year (December 2022 ARR: £1.8 million).

Bookings for the period are expected to be at least £1.22 million (H1 2022: £1.18 million) and revenue is expected to be no less than £1.1 million (H1 2022: £0.9 million), representing a 4% and 18% increase on H1 2022 respectively. Deferred revenue at 30 June 2023 was £2.9 million (30 June 2022: £1.9 million).

Osirium has continued to grow within its target sectors in the first half, with over 20 new customers signed so far in the year. This includes several contract wins in the UK healthcare sector, where the Group has established a reputation as a key provider of privileged security. This reputation contributes to Osirium's pipeline via referrals to prospective customers and direct approaches from resellers.

ARR growth was driven by new customer wins and a high rate of renewals. A significant proportion of Osirium's customer base increased their license capacity or expanded their range of products during the period, underlining the strength of the Group's land and expand strategy.

Following receipt of the Group's research and development tax credit, as announced on 13 June 2023, the Company's cash balance as at 30 June 2023 was £0.22 million, with short-term debtors of £0.40 million. The previously announced cost savings measures identified by the Group in Q4 FY22 have been fully implemented during the period, and the Board continues to keep all costs under review with a view to reducing the timeframe by which the Group will become cash flow break-even.

The strength of Osirium's offering is reflected in its speed and simplicity of implementation and tailored user experience. Reflecting this, the Group is pleased to announce it has recently been named by independent researchers, SoftwareReviews, as a 'flagship leader' in Privileged Access Management. The report ranked Osirium number one for vendor support, while also being 'top rated' in 14 other categories including usability and intuitiveness, ease of implementation, and ease of customisation. The report, assessing 14 PAM providers, awarded Osirium a Gold Medal for its overall score of 8.7/10, outperforming other major players within privileged security1.

Outlook

The Group is pleased to report a strong start to H2 2023, with a healthy pipeline underlined by a growing pool of prospective new customers, as well as expected customer renewals, and contract expansions and upsells which are expected to contribute to an increase in ARR at FY23.

Notwithstanding the positive trading momentum in the first half of the year, the Directors anticipate that the Company will be required to raise additional capital before the end of the year and are exploring all options in this regard. The Company has also identified additional cost saving measures which are being implemented.

The Group expects to announce its interim results in September 2023.

1 https://www.softwarereviews.com/products/osirium-pam

Stuart McGregor, Chief Executive Officer of Osirium, commented:

"We are pleased to deliver a period of significant annual recurring revenue growth, reflecting the sizeable market demand for privileged security and the effectiveness our land and expand strategy.

"Enabled by our channel partner network, we are seeing our positive reputation and strong industry relationships unlocking new opportunities throughout the half. On this note, I'm delighted to see our status as an agile, easy to deploy provider recognised by SoftwareReviews.

"The momentum seen in H1 has continued to date and, with a healthy pipeline of opportunities ahead, we look forward to the second half with confidence."

Contacts:

Osirium Technologies plc

Tel: +44 (0)1183 242 444

Stuart McGregor, Chief Executive Officer

Rupert Hutton, Chief Financial Officer

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)

Tony Quirke / Stefano Aquilino (Sales and Corporate Broking)

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

Will Ellis Hancock

 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQDLFFXDLLBBX
Date   Source Headline
1st Nov 202211:00 amRNSPrice Monitoring Extension
1st Nov 20227:00 amRNSQ3 2022 trading update
23rd Sep 202211:06 amRNSSecond Price Monitoring Extn
23rd Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20222:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20222:00 pmRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
20th Sep 20227:00 amRNSSignificant contract extension
12th Sep 20227:00 amRNSNotice of Results
3rd Aug 20227:00 amRNSSignificant contract extension
21st Jul 20227:00 amRNSContract Win
8th Jul 20227:00 amRNSTrading Update
8th Jun 20224:40 pmRNSSecond Price Monitoring Extn
8th Jun 20224:35 pmRNSPrice Monitoring Extension
7th Jun 20221:02 pmRNSResult of AGM
30th May 20227:00 amRNSContract win for PEM solution
17th May 20227:00 amRNSFirst contract win in the United States
11th May 20227:00 amRNSReport and Accounts and Notice of AGM
5th May 20224:41 pmRNSSecond Price Monitoring Extn
5th May 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20224:41 pmRNSSecond Price Monitoring Extn
27th Apr 20224:36 pmRNSPrice Monitoring Extension
25th Apr 20224:41 pmRNSSecond Price Monitoring Extn
25th Apr 20224:35 pmRNSPrice Monitoring Extension
21st Apr 202211:05 amRNSSecond Price Monitoring Extn
21st Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 20227:00 amRNSFinal Results
8th Apr 20222:06 pmRNSSecond Price Monitoring Extn
8th Apr 20222:00 pmRNSPrice Monitoring Extension
7th Apr 20222:05 pmRNSSecond Price Monitoring Extn
7th Apr 20222:00 pmRNSPrice Monitoring Extension
7th Apr 20229:00 amRNSPrice Monitoring Extension
6th Apr 20222:06 pmRNSSecond Price Monitoring Extn
6th Apr 20222:01 pmRNSPrice Monitoring Extension
6th Apr 202211:05 amRNSSecond Price Monitoring Extn
6th Apr 202211:00 amRNSPrice Monitoring Extension
5th Apr 20224:41 pmRNSSecond Price Monitoring Extn
5th Apr 20224:36 pmRNSPrice Monitoring Extension
5th Apr 20222:06 pmRNSSecond Price Monitoring Extn
5th Apr 20222:00 pmRNSPrice Monitoring Extension
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
5th Apr 20227:00 amRNSQ1 2022 Trading Update
1st Apr 20224:57 pmRNSHolding(s) in Company
31st Mar 20225:00 pmRNSTotal Voting Rights
25th Mar 20222:05 pmRNSSecond Price Monitoring Extn
25th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 20222:05 pmRNSSecond Price Monitoring Extn
24th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 20227:00 amRNSContract win for Privileged Process Automation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.